Hodgkin chemotherapy with autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Reed-Sternberg Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells T-Lymphocytes Neural Stem Cells Bone Marrow Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Neoplastic Stem Cells Spermatogonia Plant Stems Allografts

Organisms5

Transplantation Chimera Mice, Inbred C57BL Mice, SCID Cytomegalovirus Herpesvirus 4, Human

Diseases53

Hodgkin Disease Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Lymphoma, B-Cell Neoplasms, Second Primary Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Leukemia, Plasma Cell Neoplasm Recurrence, Local Leukemia, Myeloid Neutropenia Leukemia Neoplasms Acute Disease Disease Progression Breast Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, AIDS-Related Hepatic Veno-Occlusive Disease Hematologic Diseases Neuroblastoma Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Mucositis Anemia, Aplastic Infection Epstein-Barr Virus Infections Medulloblastoma Lymphoproliferative Disorders Severe Combined Immunodeficiency Leukemia, Lymphocytic, Chronic, B-Cell Chromosome Aberrations Thrombocytopenia Central Nervous System Neoplasms Opportunistic Infections Postoperative Complications Disease Models, Animal Paraproteinemias Blood Group Incompatibility Bone Neoplasms Lung Neoplasms

Chemicals and Drugs51

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Cytarabine Carmustine Vincristine Thiotepa Doxorubicin Busulfan Dexamethasone Boronic Acids Pyrazines Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Antigens, CD34 Thalidomide Ifosfamide Antineoplastic Agents Prednisone Granulocyte Colony-Stimulating Factor Podophyllotoxin Mitoxantrone Idarubicin Cisplatin Carboplatin Immunosuppressive Agents Antibodies, Monoclonal Keratins, Type II Bleomycin Immunoglobulin Light Chains Vidarabine HLA Antigens Immunoconjugates Methotrexate Antilymphocyte Serum Stem Cell Factor Recombinant Proteins Cyclosporine Vinblastine Antigens, CD20 Antigens, CD Minor Histocompatibility Antigens Prednisolone Immunologic Factors Biological Markers Nitrogen Mustard Compounds Tacrolimus Antigens, CD30 Myeloma Proteins Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Disease-Free Survival Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Prospective Studies Blood Component Removal Chemotherapy, Adjuvant Histocompatibility Testing Feasibility Studies Fatal Outcome Drug Administration Schedule Risk Factors Life Tables Radioimmunotherapy Neoplasm Staging Heart Transplantation Immunotherapy Lung Transplantation Kaplan-Meier Estimate Clinical Trials as Topic Blood Transfusion, Autologous Organ Transplantation Flow Cytometry Transplantation, Isogeneic Lymphocyte Transfusion Treatment Failure Pilot Projects Positron-Emission Tomography Transplantation Immunosuppression Islets of Langerhans Transplantation Immunophenotyping Lymphocyte Depletion Predictive Value of Tests Randomized Controlled Trials as Topic Cell Separation Platelet Count Radiotherapy Pancreas Transplantation Transplantation, Heterologous Multivariate Analysis Proportional Hazards Models Cell Culture Techniques Donor Selection Severity of Illness Index Immunomagnetic Separation Immunohistochemistry Cohort Studies Leukocyte Count Stem Cell Research Drug Therapy Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Incidence Disease Models, Animal Polymerase Chain Reaction Infusions, Intravenous Colony-Forming Units Assay Transplantation, Heterotopic Immunotherapy, Adoptive Reverse Transcriptase Polymerase Chain Reaction Actuarial Analysis Blood Cell Count Neoadjuvant Therapy Lymphocyte Count Platelet Transfusion Heart-Lung Transplantation

Psychiatry and Psychology1

Phenomena and Processes25

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Dose-Response Relationship, Drug Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Cell Lineage Cell Proliferation Platelet Count Drug Resistance, Neoplasm Regeneration Immunocompromised Host Chromosome Aberrations Transplantation Tolerance Leukocyte Count Virus Activation Cell Survival Blood Cell Count Lymphocyte Count

Disciplines and Occupations2

Immunohistochemistry Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups5

Tissue Donors Siblings Unrelated Donors Living Donors Survivors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Risk Factors Life Tables Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Predictive Value of Tests Age Factors Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Donor Selection Severity of Illness Index Cohort Studies Incidence Actuarial Analysis Tissue and Organ Procurement

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Hodgkin Disease Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Stem Cells Disease-Free Survival Etoposide Cyclophosphamide Lymphoma, Non-Hodgkin Myeloablative Agonists Recurrence Cytarabine Carmustine Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Graft vs Host Disease Vincristine Thiotepa Bone Marrow Purging Survival Analysis Hematologic Neoplasms Lymphoma, Mantle-Cell Doxorubicin Whole-Body Irradiation Retrospective Studies Amyloidosis Hematopoietic Stem Cells Prognosis Busulfan Dexamethasone Boronic Acids Pyrazines Graft Survival Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Follow-Up Studies Antineoplastic Agents, Alkylating Antigens, CD34 Autografts Lymphoma, T-Cell, Peripheral Liver Transplantation Thalidomide Ifosfamide Antineoplastic Agents Prednisone Lymphoma Induction Chemotherapy Time Factors Mesenchymal Stem Cell Transplantation Granulocyte Colony-Stimulating Factor Leukapheresis Lymphoma, Large B-Cell, Diffuse Podophyllotoxin Neoplasm, Residual Transplantation Chimera Maintenance Chemotherapy Tissue Donors Leukemia, Myeloid, Acute Cord Blood Stem Cell Transplantation Lymphoma, B-Cell Cell Transplantation Neoplasms, Second Primary Kidney Transplantation Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Myelodysplastic Syndromes Reed-Sternberg Cells Mitoxantrone Idarubicin Leukemia, Plasma Cell Infusions, Spinal Cisplatin Prospective Studies Carboplatin Adult Stem Cells Blood Component Removal Chemotherapy, Adjuvant Neoplasm Recurrence, Local Immunosuppressive Agents Histocompatibility Testing Antibodies, Monoclonal Feasibility Studies Fatal Outcome Drug Administration Schedule Leukemia, Myeloid Cell Differentiation Keratins, Type II Neutropenia Risk Factors

No FAQ available that match "hodgkin chemotherapy with autologous stem cell transplantation"